Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Michel Cadoz"'
Autor:
Michelle Dickey, Eva Gonczol, David I. Bernstein, Anne Marie Duliege, Stanley A. Plotkin, Claude Meric, Phil Khoury, Klara Berencsi, Mark R. Schleiss, John M. Zahradnik, Michel Cadoz
Publikováno v:
The Journal of Infectious Diseases. 185:686-690
Development of a vaccine for prevention of congenital cytomegalovirus (CMV) disease is a priority. This study evaluated a "prime-boost" strategy by comparing the safety and immunogenicity of 3 doses of subunit CMV glycoprotein B (gB) vaccine plus MF5
Autor:
Eva Gonczol, Zsofia Gyulai, Klara Berencsi, Stuart P. Adler, Pierre Dellamonica, Jian Ben Wang, John M. Zahradnik, William I. Cox, Al M. Best, Stanley A. Plotkin, Steve Pincus, Claude Meric, Michel Cadoz
Publikováno v:
The Journal of Infectious Diseases. 180:843-846
To develop a vaccine against cytomegalovirus (CMV), a canarypox virus (ALVAC) expressing CMV glycoprotein (gB) was evaluated alone or in combination with a live, attenuated CMV vaccine (Towne). Three doses of 106.5 TCID50 of ALVAC-CMV(gB) induced ver
Autor:
Michel Cadoz, Stanley A. Plotkin
Publikováno v:
The Pediatric Infectious Disease Journal. 16:508-517
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 15:927-932
A diphtheria and tetanus toxoid two-component acellular pertussis vaccine (DTaP), consisting of 25 micrograms glutaraldehyde-detoxified pertussis toxin (PT) and 25 micrograms native filamentous hemagglutinin (FHA), was compared with diphtheria and te
Publikováno v:
Biology of Blood and Marrow Transplantation. 14(2)
Autor:
Robert Schrader, Michel Cadoz, Pierre Michetti, Philip Bedford, Ciaran P. Kelly, Thomas P. Monath, Cynthia K. Lee, Bruno Guy, Stavros Sougioultzis, Mazen Alsahli, Subhas Banerjee
Publikováno v:
Vaccine. 21(3-4)
Low dose E. coli heat-labile enterotoxin (LT), delivered orally or enterically, has been used as an adjuvant for Helicobacter pylori ( H. pylori ) urease in healthy adults. In this study we aim to test the safety and adjuvant efficacy of LT delivered
Autor:
Emmanuel Vidor, Delphine Seguin, Veronique Mazarin, Bachra Rokbi, Bruno Guy, Michel Cadoz, François Mion, Marie-José Quentin-Millet
Despite increasing knowledge on the biology of Helicobacter pylori , little is known about the expression pattern of its genome during infection. While mouse models of infection have been widely used for the screening of protective antigens, the reli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9142da850eeadfae5fa5353a77742e9b
https://europepmc.org/articles/PMC98562/
https://europepmc.org/articles/PMC98562/
Autor:
Zsofia Gyulai, Susan Michelson, Michel Cadoz, Stanley A. Plotkin, Steve Pincus, Klara Berencsi, Laszlo Kari, William I. Cox, Eva Gonczol, John M. Zahradnik, Claude Meric, Stuart E. Starr
Publikováno v:
The Journal of infectious diseases. 183(8)
The major matrix phosphoprotein 65 (pp65) of cytomegalovirus (CMV) is an important target of HLA-restricted cytotoxic T cells (CTL) after natural infection. A canarypox-CMV pp65 recombinant was studied for its ability to induce CMV pp65-specific CTL,
Autor:
Michel Cadoz
Publikováno v:
Vaccine. 16(14-15)
Of infections caused by encapsulated bacteria, those due to Haemophilus influenzae b (Hib) are among the most restricted to infancy and require very early immunisation. Hib capsular polysaccharide (CPS) has the most typical T-cell independent profile
Autor:
Marie-Pierre Préziosi, Coumba Toure Kane, Steven G. F. Wassilak, Isabelle Iteman, Michel Cadoz, Souleymane Mboup, Laurence Chabirand, A. Yam, Nicole Guiso, Agnes Hoffenbach, François Simondon, Kim Knudsen, Gary Sanden
A randomized, double-blind trial comparing a diphtheria-tetanus-acellular pertussis vaccine (DTaP) (pertussis toxoid and filamentous hemagglutinin) with a whole-cell vaccine (DTwP) was conducted. A case-contact study was nested in the trial to estima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c1683a73d4f2623c8ee137faa86058b
http://www.documentation.ird.fr/hor/fdi:010012045
http://www.documentation.ird.fr/hor/fdi:010012045